EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles (PMSC-EVs) as an Innovative Therapy for Diabetic Wound Healing

Hady S Omar, Amal Abdul-Hafez iD, Ranga Prasanth Thiruvenkataramani iD, Suraj Karanje, Sherif Abdelfattah Ibrahim iD, Sarah Jameel Mohammadi, Burra V Madhukar, Said A Omar iD

International Journal of Molecular Sciences · 30.04.2026 · 27 (9) · 4053

DOI: 10.3390/ijms27094053 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.04.2026. Verfasst von Hady S Omar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824…. Hauptthemen laut MEDLINE: Wound Healing, Mesenchymal Stem Cells, Extracellular Vesicles, Placenta. Die Arbeit nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with diabetes mellitus (DM) experience impaired wound healing, where the healing process is often compromised by a complex, hostile microenvironment characterized by persistent inflammation, high oxidative stress, and dysfunctional angiogenesis. The hyperglycemic environment damages the blood vessels and disturbs the normal hypoxia-induced upregulation of vascular endothelial growth factors, causes poor vascularization and insufficient production of new blood vessels, and leads to impaired perfusion and thickened and dysfunctional capillary basement membranes, which reduce blood flow to the wound, leading to delayed wound healing. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) are the main effectors of intercellular communication and have emerged as a potent cell-free strategy for the acceleration of tissue repair. MSC-EVs can be isolated from various adult tissues, but increasing evidence suggests that placental MSC-derived EVs (PMSC-EVs) possess distinct clinical and biological advantages for enhancing diabetic wound healing. Placentas are unique cell sources for PMSCs, which can be easily acquired non-invasively from a discarded placenta and is ethically acceptable, and have superior proliferative capacity. The cargo of PMSC-derived EVs contains macromolecules such as proteins, mRNA, miRNA, and lipids, which may be tailored for fetomaternal tolerance and translates to unmatched immunomodulatory potential for resolving chronic diabetic inflammation. The PMSC-derived EVs also aid in enhancing multiple pathways, including modulation of inflammation, angiogenesis, and epithelial proliferation, that lead to increased wound healing. This article will highlight the unique advantages, specific mechanisms, and limitations of PMSC-derived EVs as an innovative non-cellular therapeutic modality in restoring vital repair processes and enhancing diabetic wound healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingMesenchymal Stem CellsExtracellular VesiclesPlacentaDiabetes MellitusDiabetes ComplicationsHumansFemalePregnancyAnimals

Stichwörter der Autor:innen

diabetes mellitusexosomesextracellular vesiclesmesenchymal stem cellswound healing

Autor:innen und Institutionen

  • Division of Neonatology, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.
  • Regional Neonatal Intensive Care Unit, University of Michigan Health-Sparrow, Lansing, MI 48912, USA.
  • Institute of Biomedicine, Faculty of Health Sciences, University of Eastern Finland, FI-70210 Kuopio, Finland.

ORCID-Profile: Amal Abdul-Hafez, Ranga Prasanth Thiruvenkataramani, Sherif Abdelfattah Ibrahim, Said A Omar

Zitieren

APA

Omar, H. S., Abdul-Hafez, A., Thiruvenkataramani, R. P., Karanje, S., Ibrahim, S. A., Mohammadi, S. J., Madhukar, B. V., & Omar, S. A. (2026). Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles (PMSC-EVs) as an Innovative Therapy for Diabetic Wound Healing. International Journal of Molecular Sciences, 27(9), 4053. https://doi.org/10.3390/ijms27094053

Vancouver

Omar HS, Abdul-Hafez A, Thiruvenkataramani RP, Karanje S, Ibrahim SA, Mohammadi SJ, et al. Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles (PMSC-EVs) as an Innovative Therapy for Diabetic Wound Healing. International Journal of Molecular Sciences. 2026;27(9):4053. doi:10.3390/ijms27094053

BibTeX
@article{Omar2026,
  author = {Omar, Hady S and Abdul-Hafez, Amal and Thiruvenkataramani, Ranga Prasanth and Karanje, Suraj and Ibrahim, Sherif Abdelfattah and Mohammadi, Sarah Jameel and Madhukar, Burra V and Omar, Said A},
  title = {Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles (PMSC-EVs) as an Innovative Therapy for Diabetic Wound Healing},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {4053},
  doi = {10.3390/ijms27094053}
}
Kostenlos starten →